Cargando…
The favourable effect of Helicobacter pylori eradication therapy in patients with recurrent angina-like chest pain and non-responsive to proton pump inhibitors – a preliminary study
INTRODUCTION: The outcome of Helicobacter pylori (Hp) eradication therapy from the aspect of prevention of chest pain recurrence is still uncertain. The aim of this study was to assess the influence of Hp eradication therapy on the risk of hospitalization due to acute coronary syndrome. MATERIAL AND...
Autor principal: | Budzyński, Jacek |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3258683/ https://www.ncbi.nlm.nih.gov/pubmed/22291736 http://dx.doi.org/10.5114/aoms.2011.20607 |
Ejemplares similares
-
Helicobacter pylori eradication: Not only early consequences
por: Budzyński, Jacek
Publicado: (2018) -
Comparative study: Vonoprazan and proton pump inhibitors in Helicobacter pylori eradication therapy
por: Sakurai, Kouichi, et al.
Publicado: (2017) -
Addition of cranberry to proton pump inhibitor-based triple therapy for Helicobacter pylori eradication
por: Seyyedmajidi, Mohammadreza, et al.
Publicado: (2016) -
Does Helicobacter pylori eradication or proton pump inhibitor use benefit gastroesophageal reflux disease?
por: Sakin, Yusuf Serdar, et al.
Publicado: (2015) -
Proton pump inhibitor-amoxicillin-clarithromycin versus proton pump inhibitor-amoxicillin-metronidazole as first-line Helicobacter pylori eradication therapy
por: Nishizawa, Toshihiro, et al.
Publicado: (2012)